Track topics on Twitter Track topics that are important to you
NEW YORK, NY -- (Marketwired) -- 08/12/15 -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on SpectraScience, Inc. (OTCQB: SCIE). The full 48-page report is available on Crystal Research Associates' website at www.crystalra.com.
SpectraScience, Inc. ("SpectraScience" or "the Company") is commercializing advanced, minimally invasive diagnostic products using light-based technologies that improve a physician's ability to diagnose cancer while lowering the cost of diagnosis. The Company's lead platform -- the WavSTAT® Optical Biopsy System -- is in the final stages of a multicenter, 1,200-patient European study and is poised to commence sales in Europe and potentially Saudi Arabia in 2016. The current WavSTAT4 product is initially targeted to the colorectal cancer screening market where recent colonoscopy guidelines have created opportunities for new, improved diagnostic technologies. SpectraScience is further evaluating the potential of its technology in an array of additional indications and using a combination of next-generation, light-based technologies.
Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us at http://www.crystalra.com/blog for more coverage.
About Crystal Research Associates, LLC
For the past decade, Crystal Research Associates, LLC (www.crystalra.com) has successfully articulated the exceptional stories of small- and mid-cap companies to the Wall Street investor community. Our methods are well-established and diverse, from compiling and disseminating objective, factual information for both institutional and retail investor audiences to capitalizing on our expansive line of targeted distribution channels, which include industry-leading financial data and information providers. Our distribution efforts are accompanied by the use of prominent social media channels and by strategic and targeted appearances on national news programs and print media.
Crystal Research Associates is led by Wall Street veterans, Jeffrey Kraws and Karen Goldfarb. Together, Kraws and Goldfarb have built a unique business model, capitalizing on decades of experience as an award-winning sell-side analyst team to produce institutional-quality industry and market research in a manner that is easily understood by investors and consumers. Our firm's approach has been proven successful over the years as our products are published and available on Bloomberg, Thomson Reuters/First Call, Capital IQ, FactSet, Yahoo! Finance, and scores of other popular forums.
Forward-Looking Safe Harbor Statement
Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic news and reports. Crystal Research Associates' compensation is a cash amount of forty thousand U.S. dollars and three hundred thousand warrants for its services.
These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.Contact: Jeffrey J. Kraws/Karen B. Goldfarb Crystal Research Associates, LLC P: (609) 306-2274 F: (609) 395-9339 NEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...